Company Filing History:
Years Active: 2022-2023
Title: Innovations in Cancer Treatment by Jianhuan Li
Introduction
Jianhuan Li is a notable inventor based in Chongqing, China. He has made significant contributions to the field of medicine, particularly in the development of innovative drug formulations aimed at treating cancer. With a total of two patents to his name, his work focuses on enhancing the efficacy of anticancer medications.
Latest Patents
Jianhuan Li's latest patents include a polyethylene glycol conjugate drug and its preparation method, as well as an intermediate drug with synergistic anticancer activity. The first patent relates to a polyethylene glycol conjugated drug, which is designed to improve the delivery and effectiveness of pharmaceutical treatments. This invention also encompasses a method for preparing the drug and its use in pharmaceutical compositions. The second patent introduces an intermediate drug that exhibits synergistic anticancer properties, along with a polyethylene glycol-coupled drug. This innovation aims to combine various anticancer drugs while minimizing toxic reactions and overcoming multidrug resistance in cancer treatments.
Career Highlights
Jianhuan Li is currently associated with Chongqing Upgra Biotechnology Co., Ltd., where he continues to advance his research and development efforts in the pharmaceutical sector. His work is characterized by a commitment to improving cancer treatment methodologies through innovative drug design.
Collaborations
Jianhuan Li collaborates with notable colleagues, including Gaoquan Li and Dajun Li, who contribute to his research initiatives and help drive forward the development of new therapeutic solutions.
Conclusion
Jianhuan Li's contributions to the field of medicine, particularly in cancer treatment, highlight the importance of innovation in pharmaceutical development. His patents reflect a dedication to improving patient outcomes through advanced drug formulations.